Skip to main content

Patients, providers and payers alike are investing in GLP-1 medications - but are they seeing the value they expected?

  

GLP-1 Persistence: A Key Component of Weight Loss

In this ~2-minute video, Omada's Senior Director of Clinical and Translational Research, Sarah Linke, summarizes findings of our July 2025 clinical white paper: GLP-1 Persistence: A Key Component of Weight Loss.